Biotech · Private company
HbO2 Therapeutics LLC
Track this companyFree. Adds HbO2 Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials3
- Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening AnemiaNA · ENROLLING_BY_INVITATION · started Oct 1, 2013ClinicalTrials.gov NCT01881503 · fetched Nov 12, 2026
- Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute AnemiaNO_LONGER_AVAILABLEClinicalTrials.gov NCT03633604 · fetched Nov 12, 2026
- Expanded Access Protocol Using HBOC-201NO_LONGER_AVAILABLEClinicalTrials.gov NCT02684474 · fetched Nov 12, 2026